Doctolib, online doctor booking platform raises USD42 million

Doctolib, online doctor booking platform raises USD42 million

French doctor appointment booking platform, Doctolib has raised USD42 million to scale its operations across Europe.

The raising is said to be the largest in France’s e-health sector that is maturing. This is because Doctolib handles over 7 million bookings monthly.

The company said the fundraising was carried out with Bpifrance, already present in the capital, and Eurazeo, one of the first listed investment companies in Europe. Thanks to this contribution, Doctolib wants to accelerate its development in France and Germany and launch new services to change the health of Europeans.

Doctolib will use the funds to accelerate its international expansion, especially in Germany, and develop new digital services to radically transform healthcare in Europe. The biggest capital raise for a healthtech company in Europe in 2017 With two financing rounds this year, Doctolib holds the investment record for the European healthtech sector in 2017 – 61 million euros. Since its creation in 2013, the company has raised 85 million euros from Accel, Kerala Ventures and from French and German entrepreneurs, including Pierre KOSCIUSKO-MORIZET, Nicolas BRUSSON, Bertrand JELENSPERGER, Maxime FORGEOT and Ludwig KLITZSCH.

This new round confirms the strength of Doctolib’s value proposition, the relevance of its strategic vision and the confidence of investors in its growth potential.

It also demonstrates that digital health is becoming more and more relevant for the European economy and is a key segment for investors. With over 30,000 health professionals using the platform, 800 partner healthcare facilities (public and private) and 12 million visitors on its French and German websites each month, Doctolib is already the most used e-health service in Europe.

“Bpifrance is a natural partner for Doctolib due to its societal impact and direct contribution towards improving the health system, its international operations and European convictions, and its long-term vision, which is consistent with our mission as a public investor. As in January, the choice to renew our support in Doctolib was obvious,” explains Nicolas HERSCHTEL, Executive Director of Innovation at Bpifrance.